메뉴 건너뛰기




Volumn 344, Issue 17, 2001, Pages 1294-1303

Global trends in resistance to antituberculosis drugs

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

EID: 0035953598     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200104263441706     Document Type: Article
Times cited : (644)

References (36)
  • 4
    • 0031951956 scopus 로고    scopus 로고
    • Guidelines for surveillance of drug resistance in tuberculosis
    • (1998) Int J Tuberc Lung Dis , vol.2 , pp. 71-89
  • 15
    • 0027272060 scopus 로고
    • Pitfalls in the care of patients with tuberculosis: Common errors and their association with the acquisition of drug resistance
    • (1993) JAMA , vol.270 , pp. 65-68
    • Mahmoudi, A.1    Iseman, M.D.2
  • 35
    • 0021812931 scopus 로고
    • Controlled clinical trial of two 6-month regimens of chemotherapy in the treatment of pulmonary tuberculosis
    • (1985) Am Rev Respir Dis , vol.131 , pp. 727-731
  • 36
    • 0017710095 scopus 로고
    • Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong: The results up to 30 months
    • (1977) Am Rev Respir Dis , vol.115 , pp. 727-735


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.